Key Events This Week
2 Feb: Stock opens week at Rs.574.90, down 2.21%
3 Feb: Q3 FY26 results announced, showing strength but raising long-term growth concerns
4 Feb: Intraday high with 11.42% surge, stock hits Rs.610
6 Feb: Week closes at Rs.631.90, up 0.45% on day

Amrutanjan Health Care Ltd is Rated Hold
2026-02-07 10:10:05Amrutanjan Health Care Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Nov 2025. While the rating change occurred then, the analysis and financial metrics discussed here reflect the company’s current position as of 07 February 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleHas Amrutanjan Health Care Ltd declared dividend?
2026-02-05 23:30:56Amrutanjan Health Care Ltd has declared a dividend. Dividend Details: - Percentage announced: 100% - Amount per share: 1 per share - Ex-date: 06 Feb 26 Dividend Yield: 0.72%. Total Returns by Period: In the 3 Months period, the price return was -12.24%, the dividend return was 0.28%, resulting in a total return of -11.96%. In the 6 Months period, the price return was -8.61%, the dividend return was 0.70%, leading to a total return of -7.91%. In the 1 Year period, the price return was -6.2%, the dividend return was 0.85%, resulting in a total return of -5.35%. In the 2 Years period, the price return was 9.64%, the dividend return was 1.55%, leading to a total return of 11.19%. In the 3 Years period, the price return was -10.97%, the dividend return was 2.35%, resulting in a total return of -8.62%. In the 4 Years period, the price return was -24.41%, the dividend return was 2.20%, leading to a total r...
Read full news articleWhy is Amrutanjan Health Care Ltd falling/rising?
2026-02-05 00:54:22
Recent Price Movement and Market Context
Amrutanjan Health Care's stock has outperformed its sector considerably on the day, registering a gain that exceeded sector returns by 10.01%. The stock opened with a gap up of 3.45%, signalling positive investor sentiment from the outset. Intraday, the share price reached a high of ₹652, marking a 12.23% increase from the previous close, before settling slightly lower but still maintaining a robust gain. This price action was accompanied by notable volatility, with an intraday volatility of 5.2%, indicating active trading and investor interest.
Over the past week, the stock has gained 8.43%, significantly outperforming the Sensex's 1.79% rise. However, the one-month and year-to-date returns remain negative at -4.98% and -4.51% ...
Read full news articleAre Amrutanjan Health Care Ltd latest results good or bad?
2026-02-04 19:20:00Amrutanjan Health Care Ltd's latest financial results for Q3 FY26 indicate a mixed operational performance. The company reported net sales of ₹141.04 crores, reflecting a year-on-year growth of 14.90% compared to ₹122.75 crores in the same quarter last year. This growth demonstrates a strong sequential momentum, attributed to seasonal demand for its pain relief and wellness products during the winter months. However, the net profit for the quarter was ₹19.45 crores, which represents a modest year-on-year growth of 1.04%, indicating that while revenues have expanded significantly, profit growth has not kept pace. The operating profit margin improved to 17.85%, marking a recovery from 14.04% in the previous quarter, yet it contracted from 19.01% in the same quarter last year. This suggests that despite the increase in revenues, the company is facing challenges in maintaining profitability, potentially due to...
Read full news article
Amrutanjan Health Care Ltd Hits Intraday High with 11.42% Surge on 4 Feb 2026
2026-02-04 11:30:56Amrutanjan Health Care Ltd recorded a robust intraday performance on 4 Feb 2026, surging 11.42% to touch a day’s high of Rs 610, significantly outperforming the Pharmaceuticals & Biotechnology sector and broader market indices.
Read full news article
Amrutanjan Health Care Q3 FY26: Strong Quarter Masks Long-Term Growth Concerns
2026-02-03 19:30:42Amrutanjan Health Care Ltd., the Chennai-based pain relief and wellness products manufacturer, delivered a robust third quarter performance for FY2026, with net profit surging 39.27% quarter-on-quarter to ₹19.45 crores and revenue climbing 19.83% sequentially to ₹141.04 crores. However, the stock has struggled significantly, declining 11.67% over the past year and underperforming the broader Sensex by over 20 percentage points, as investors remain concerned about the company's modest long-term growth trajectory and stretched valuations.
Read full news articleWhen is the next results date for Amrutanjan Health Care Ltd?
2026-01-29 23:16:08The next results date for Amrutanjan Health Care Ltd is scheduled for February 3, 2026....
Read full news article
Amrutanjan Health Care Ltd is Rated Hold
2026-01-27 10:10:03Amrutanjan Health Care Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 January 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article





